Mia's Feed
Medical News & Research

Continued Use of Antiseizure Medications During Pregnancy Despite Risks

Continued Use of Antiseizure Medications During Pregnancy Despite Risks

Share this article

A recent study highlights the ongoing use of antiseizure medications during pregnancy, with some drugs posing known or uncertain risks to fetal development. The research calls for better management and awareness, especially among socioeconomically disadvantaged populations.

2 min read

Despite clear evidence indicating the risk of birth defects associated with certain antiseizure medications, their use during pregnancy persists, according to a recent study published in Neurology. The research highlights ongoing concerns about the safety of these drugs for pregnant women, especially as usage for some medications with uncertain or known risks continues to rise. The study utilized comprehensive data from a French national pregnancy registry covering the years 2013 to 2021, analyzing over 55,800 pregnancies exposed to at least one antiseizure medication.

Findings reveal that the use of the safest antiseizure drugs, such as lamotrigine and levetiracetam, increased by 30% over the study period. Conversely, the use of medications with known high risks, like valproic acid and valpromide, decreased significantly—by more than 80%. Despite these improvements, the study notes that some pregnant women still receive medications with known or uncertain risks, including newer drugs like pregabalin, gabapentin, lacosamide, and zonisamide.

One concerning aspect of the study is the disproportionate use of these medications among socioeconomically disadvantaged populations. Women with lower resources, defined by income and access to healthcare support programs, were more likely to take drugs with higher or uncertain risks during pregnancy. The authors suggest that factors such as unplanned pregnancies and inadequate preconception care may contribute to this disparity.

The researchers emphasize the need for continued efforts to reduce exposure to high-risk medications during pregnancy, especially among vulnerable groups. They also highlight limitations of the study, noting that medication exposure was based on claims data rather than confirmed medication adherence. Overall, the findings underscore the importance of careful medication management and counseling for women of reproductive age who require antiseizure drugs.

For more information, the full study is available in Neurology (2025). Source: https://medicalxpress.com/news/2025-07-antiseizure-drugs-uncertain-pregnancy.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Rising Trends in HIV Pre-Exposure Prophylaxis Use Among Young Adults: Progress and Challenges

A new study reveals a significant rise in HIV-preventive medication use among young adults, highlighting progress and ongoing challenges in HIV prevention efforts.

Unveiling Human DNA's Hidden Potential Inspired by Hibernating Animals

New genetic research uncovers how hibernating animals' remarkable resilience might be encoded in human DNA. Discover how controlling genetic switches could lead to breakthroughs in treating neurodegeneration, obesity, and metabolic disorders.

New Research Reveals Risks of Cannabis Vaping on Lung Health

New research from McGill University reveals that vaping cannabis releases toxic and cancer-linked substances that can harm lung cells, challenging the perception that vaping is a safer alternative to smoking.